02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
 
/ Home
/ Target Audience

Pharmaceutical Companies

Target Audience:Pharmaceutical Companies

Pharmaceutical Companies need to monitor trial results in real time at all participating sites to take earlier “Go” or “No Go” decisions.

  • LMS provides centralized data management with unique multi-site integration capabilities to store all lesion measures and make them available at all times.
  • Lesion measures stored in the centralized data management system can then be correlated with other functional or anatomical information.

 

Regulatory authorities require pharmaceutical companies to conform to international criteria such as RECIST to evaluate drug effectiveness.

  • LMS automatically generates reports according to RECIST criteria.
  • LMS provides automatic and consistent quantification of lesion growth to limit discordance.

 

Lesion volume and attenuation changes bring additional value to assess molecule behavior and drug effectiveness.

  • LMS provides volume growth and attenuation values and histogram.
  • Volume and attenuation values and changes are stored in the centralized data management system along with diameter information.